Earth Science Tech Inc. (OTC: ETST) reported fiscal year 2026 results for the year ended March 31, 2026, showcasing growth across key financial metrics as it continues to execute its diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate, and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to ETST's efforts to fully integrate the patient experience across telemedicine to pharmacy to fulfillment. This integration is the core of the company's value proposition, achieved through the synergy of specialized subsidiaries. The company operates as a diversified holding company focused on the health and wellness sector, building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. Healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
The significance of this announcement lies in the company's progress toward creating a seamless patient journey from initial consultation through medication delivery. By connecting telemedicine, pharmacy, and fulfillment, Earth Science Tech aims to reduce friction in healthcare delivery and improve patient outcomes. This integrated model could position the company to capture a larger share of the growing telehealth and direct-to-patient pharmacy markets.
For more details, the full article is available at https://nnw.fm/u6mhk. Additional information about Earth Science Tech can be found at www.EarthScienceTech.com. For the latest news and updates relating to ETST, visit the company's newsroom at https://nnw.fm/ETST.
